
Professional Guidelines Included
Learn the Computer navigated P1 hemipelvectomy for chondrosarcoma and GRAFTJACKET (Wright Medical) reconstruction surgical technique with step by step instructions on OrthOracle. Our e-learning platform contains high resolution images and a certified CME of the Computer navigated P1 hemipelvectomy for chondrosarcoma and GRAFTJACKET (Wright Medical) reconstruction surgical procedure.
Chondrosarcoma (CS) is the second most common primary malignant bone sarcoma, and the most common in adults. These tumours range from low to high-grade malignant cartilage tumours which may metastasise to the lungs. They are relatively insensitive to chemo- or radiotherapy, due to hypovascularity, meaning that surgery is the principal treatment. Five year survival ranges from 99% for low grade to 24% for dedifferentiated chondrosarcomas.
The pelvis is the fourth most common site of primary malignant bone tumours in all age groups after the distal femur, proximal femur and proximal humerus. Chondrosarcomas can also arise in other pre-existing conditions, particularly multiple osteochondromas and multiple enchondromatosis (e.g. in Ollier disease and Maffucci syndrome).Enneking and Dunham classified pelvic resections into: type I (ilium), type II (periacetabular), and type III resection (obturator). Resections involving the sacrum are referred as type IV. Achieving adequate surgical margins to ensure the tumour is excised-bloc is the guiding oncological principle to avoid local recurrence; local recurrence is often accompanied by metastasis and can only be controlled by en-bloc excision with wide surgical margins. Resection of a tumour from the pelvis often requires reconstruction of the large bone and soft-tissue defect; partial resection of the ileum preserves the pelvic ring which is thought to maximise function but risks inadequate surgical margins and herniation of the peritoneum through the resultant defect. Reconstruction of the pelvic bone and soft-tissue defect using the Graftjacket (Wright Medical), a human dermal allograft matrix commonly used in foot & ankle and shoulder surgery to repair soft-tissue defects, is a novel use for this device (http://www.wright.com/healthcare-professionals/graftjacket).
Here I describe the use of computer navigation to excise a pelvic chondrosarcoma and reconstruct the defect using a Graftjacket.
Enneking WF, Dunham WK. Resections and reconstruction for primary neoplasms involving the nominate bone. J Bone J Surg (Am) 1978;60(6):731-746. PMID: 701308

INDICATIONS
The indications for hemi-pelvic excision are primary and secondary malignant tumours, but in rare cases of infection or trauma pelvic resections may be required. Type I resections (ileum) are the least challenging resections and reconstructions. If the ilio-ischial bar can be retained, as in this particular case using navigated assisted surgery, then the pelvic ring can be preserved and limited if any reconstruction is required. At most, to prevent visceral herniation a Graftjacket (Wright Medical) collagen matric scaffold can be used to replace the resected ileum for reattachment of the abdominal and gluteal muscles.
If the ilio-ischial bar is resected, then the pelvic ring has been disrupted and load through the acetabulum cannot be transmitted to the sacrum. Options include avoiding reconstruction (after neo-adjuvant photon or proton therapy to minimise the risk of infection), reconstructing the pelvic ring with autogenous fibula strut graft which may be vascularised or non-vascularised, with or without osteosynthesis.
SYMPTOMS & EXAMINATION
Patients with primary bone tumours present principally with pain and swelling, with or without limitation of motion and reduced ability to bear weight. With pelvic tumours, particularly arising from the inner table, they may reach considerable size before causing symptoms leading to presentation. If a pelvic tumour has invaded the greater sciatic notch then motor and sensory radiculopathy can sometimes be evident. Often if the tumour involves the pubis, the extrinsic pressure on the femoral vein and lymphatics can lead to generalised oedema of the limb and thrombosis in the femoral vein should be excluded in these cases.
When examine the patient specific features to investigate and document include the biopsy tract, previous scars (inguinal hernia repairs or caesareans), range of hip motion of hip, limb-length, neurovascular status, skin quality including previous scars and sinuses, abductor function, availability of local soft tissue flaps as required.
IMAGING & INVESTIGATIONS
Plain AP radiograph of the pelvis is required to delineate the size and location of the tumour as well as extra-osseous extension. Radiographs are assessed for the extracellular matrix deposition of the tumour be that osteoid (e.g. osteosarcoma), chondroid (e.g. chondrosarcoma) or fibrous (fibrosarcoma of bone) which hints at the diagnosis.
Patients undergo biopsy to confirm the histological diagnosis. In our centre biopsies either occur in the operating theatre using a Jamshidi needle and fluoroscopy or CT guidance via a direct lateral approach. The positioning of the biopsy tract is crucial to ensure that is does not cross more than one anatomical compartment or compromise vital structures as the biopsy tract is excised en-bloc at the time of surgery. Typically the histological biopsy results take 7 to 10 days to be reported and are discussed at the sarcoma multi-disciplinary team (MDT) meeting comprising orthopaedic surgeons, radiologists, pathologists and oncologists. For pelvic tumours, easily excisable biopsy tracts include the anterior inferior iliac spine and the posterior superior iliac spine, but an individual approach is required in each case and should be planned by the surgeon who will undertake definitive resection.
Prior to surgery patients are ‘staged’, which involves local staging of the effected bone (i.e. MRI scan of the pelvis including the hip joints) and distal staging to include CT chest and whole-body imaging e.g. bone scintigraphy, whole-body MRI or whole-body PET-CT, to exclude metastatic disease. If metastases are identified at the time of diagnostic staging this may influence the extent of surgical and systemic treatment but may not preclude surgical excision of the primary tumour; all of these details are considered at the sarcoma MDT when deciding upon the optimum treatment by all involved specialists. Although the British Sarcoma Group guidelines recommend whole-body staging of chondrosarcomas, evidence is now emerging to suggest this may not be necessary as the incidence of bone metastases is very low at diagnosis.
Enneking and Dunham classified pelvic resections into: type I (ilium), type II (periacetabular), and type III resection (obturator). Resections involving the sacrum are referred as type IV. Achieving adequate surgical margins to ensure the tumour is excised-bloc is the guiding oncological principle to avoid local recurrence; local recurrence is often accompanied by metastasis and can only be controlled by en-bloc excision with wide surgical margins. Resection of a tumour from the pelvis often requires reconstruction of the large bone and soft-tissue defect depending upon the defect.
ALTERNATIVE OPERATIVE TREATMENT
For chondrosarcomas of the pelvis, alternatives to en-bloc excision do not yet exist. With the advent of genomics, IDH may in the future offer an adjuvant to surgery, and there are some reports from the US regarding the role of radiotherapy in pelvic chondrosarcoma, but this is not routinely offered elsewhere.
NON-OPERATIVE MANAGEMENT
For chondrosarcoma the principle treatment is en-bloc excision and reconstruction as these are relatively chemo- and radiotherapy insensitive tumours.
For other primary pelvic bone tumours, patients typically receive pre-operative chemotherapy, then surgical resection and reconstruction followed by further post-operative chemotherapy. Some tumours, such as Ewing’s sarcoma, are relatively sensitive to radiotherapy (protons) and we prefer to give protons pre-operatively because there is some emerging evidence this has a survival advantage over post-op protons.
CONTRAINDICATIONS
If the patient was medically unfit to undergo major surgery or if the staging revealed that the disease had already spread to the lungs with a very poor prognosis then surgery may be contraindicated although palliative surgery to control pain may still be contemplated.

Whilst the patient is being anaesthetised the patient CT & MRI scans are uploaded to the navigation system (Stryker NAV3i) and the two scans are fused and registration points that can be identified intra-operatively are planned. We then plan multiple osteotomies as required to excise the bone tumour.
Typically pelvic cases undergo combined epidural and spinal anaesthesia (Bupivacaine) using to achieve good post-operative pain relief and reduce peri-operative venous load to minimise blood loss. Urinary catheters, bowel preparation, central line and arterial cannulae are all mandatory. Prophylactic antibiotics (broad spectrum Fluxcloxacillin and Gentmicin, unless penicillin allergy) and tranexamic acid are also given immediately pre- and post-operatively.

Bed rest 48 hours
Protected weight bearing 3 months
VTE prophylaxis: LMWH 28 days and TED stockings 6 weeks
VAC dressing change after 7 days
Removal of clips 14 days
Histology results to new reviewed in bone sarcoma MDT when ready
Standard high grade sarcoma surveillance: clinical review and Xray fo the local site and chest every 3 months for the first two years, then six monthly until year 5, then annually until year 10 post-operatively.

Partial iliac resections, in this case made possible due to navigated assisted surgery, have been shown by Laitinen et al. to have the best functional outcomes compared to total iliac resections with and without reconstruction (Laitinen MK, et al. Resection of the ileum in patients with a sarcoma. Bone Joint Journal 2017;99-B:538–43. https://online.boneandjoint.org.uk/doi/abs/10.1302/0301-620X.99B4.BJJ-2016-0147.R1), although the partial resection group had the highest risk of local recurrence. Therefore, as ever in oncology surgery, the balance between oncological outcomes and functional loss must be explored by surgeons with patients pre-operatively, however achieving wide surgical margins remains the guiding principle.
The use of navigation in pelvic oncology surgery has following advantages: Optimal surgical bone margins, reduction in operative time, beneficial in complex pelvic or peri-acetabular resections and more accurate implant or allograft implantation and reconstruction. However, navigation is expensive, takes time to prepare and setup and is associated with a learning curve as with all new techniques in surgery (Morris G, et al. Navigation in Musculoskeletal Oncology: an Overview. Indian J Orthop 2018 52(1): 22–30. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791227/). Despite promising early results with navigation assisted surgery, local recurrence has remained a problem in the longer-term and we advise against compromising resection to preserve function, and encourage surgeons to reduce local recurrence by prioritising wide resection margins of the tumour (Nandra R, et al. Long-term outcomes after an initial experience of computer navigated resection of primary pelvic and sacral tumours: soft-tissue margins must be adequate to reduce local recurrences. Bone Joint J 2019;101-B:484–490. https://online.boneandjoint.org.uk/doi/abs/10.1302/0301-620X.101B4.BJJ-2018-0981.R1).
Overall ten year survival for axial and appendicular chondrosarcoma is approximately 70%. The incidence of local recurrence is 26% and metastasis 32% (Fiorenza F, et al. Risk factors for survival and local control in Chondrosarcoma of bone.J Bone Joint Surg [Br] 2002;84-B:93-9. https://pdfs.semanticscholar.org/b0b7/d284cd20ce1bdc6b705eb2f571c465c65e68.pdf)
Independent risk factors predictive of survival include extracompartmental spread, development of local recurrence and high histological grade. Independent risk factors for local recurrence include inadequate surgical margins and tumour size greater than 10 cm. Surgical excision with an oncologically wide margin provides the best prospect both for cure and local control in these patients. The challenge is distinguishing low grade from high grade tumours on pre-operative biopsy; recently it has been shown that histological grade cannot be accurately pre-determined with biopsy due to sampling error (Laitinen MK, et al. The role of grade in local recurrence and the disease specific survival in chondrosarcomas. Bone Joint J 2018;100-B:662–6. https://online.boneandjoint.org.uk/doi/abs/10.1302/0301-620X.100B5.BJJ-2017-1243.R1). Consequently it is recommended that any pelvic chondrosarcoma should undergo surgery aiming to achieve wide resection margins due to the high chance that a low grade tumour turns out to be a high grade tumour once resected and the whole of the tumour has been histopathologically assessed (Bus, M, et al. Conventional primary central chondrosarcoma of the pelvis. J Bone J Surg (Am)2018;100:316-25. https://dl.uswr.ac.ir/bitstream/Hannan/35979/1/2018%20AJBJS%20Volume%20100%20Issue%205%20March%20%286%29.pdf).
Previous research has demonstrated that the optimum surgical margin (ie the closest distance between the tumour and cut surface of the specimen) is 4mm in appendicular chondrosarcomas, beyond which a greater surgical margin has no improvement in local recurrence, which determines survival in high grade tumours (Stevenson JD, et al. the role of surgical margins in chondrosarcoma. EJSO 2018;44(9):1412-18. https://www.sciencedirect.com/science/article/pii/S0748798318311168). Recent and as yet unpublished local research has shown that a minimum surgical margin of 2mm is required to minimise the risk of local recurrence and optimise survival chances in pelvic chondrosarcoma resections.
If chondrosarcoma patient suffer local recurrence, the survival of the patient can be influenced if they undergo further excision achieving wide resection margins (Laitinen MK, et al. Locally recurrent chondrosarcoma of the pelvic and limbs can only be controlled by wide excision. Bone Joint J 2019;101-B:266–271. https://online.boneandjoint.org.uk/doi/abs/10.1302/0301-620X.101B3.BJJ-2018-0881.R1).
Reference
- orthoracle.com



































































